Detalles de la búsqueda
1.
Targeting PD-1 in CD8+ T Cells with a Biomimetic Bilirubin-5-fluoro-2-deoxyuridine-Bovine Serum Albumin Nanoconstruct for Effective Chemotherapy against Experimental Lymphoma.
Mol Pharm
; 18(5): 2053-2065, 2021 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33886324
2.
Telomerase Responsive Delivery of Doxorubicin from Mesoporous Silica Nanoparticles in Multiple Malignancies: Therapeutic Efficacies against Experimental Aggressive Murine Lymphoma.
Bioconjug Chem
; 29(6): 2107-2119, 2018 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29800519
3.
Studies on interaction potency model based on drug synergy and therapeutic potential of triple stimuli-responsive delivery of doxorubicin and 5-fluoro-2-deoxyuridine against lymphoma using disulfide-bridged cysteine over mesoporous silica nanoparticles.
J Mater Chem B
; 8(7): 1411-1421, 2020 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31974541
4.
Pepsin Assisted Doxorubicin Delivery from Mesoporous Silica Nanoparticles Downsizes Solid Tumor Volume and Enhances Therapeutic Efficacy in Experimental Murine Lymphoma.
ACS Appl Bio Mater
; 1(6): 2133-2140, 2018 Dec 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34996274
5.
ATP-Decorated Mesoporous Silica for Biomineralization of Calcium Carbonate and P2 Purinergic Receptor-Mediated Antitumor Activity against Aggressive Lymphoma.
ACS Appl Mater Interfaces
; 10(8): 6917-6929, 2018 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29392934
6.
Protease-Responsive Targeted Delivery of Doxorubicin from Bilirubin-BSA-Capped Mesoporous Silica Nanoparticles against Colon Cancer.
ACS Biomater Sci Eng
; 3(12): 3376-3385, 2017 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33445377
Resultados
1 -
6
de 6
1
Próxima >
>>